Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Mededportal : the Journal of Teaching and Learning Resources|February 26, 2019
Lived Experience and Patient Advocacy Module: Curriculum and Faculty GuideLaurie Gerber, John F Mahoney, Phil GoldAmerican Journal of Preventive Medicine|October 4, 2011
Overcoming challenges to integrating public and population health into medical curriculaJohn F Mahoney, Mark D Fox, Shobhina G ChhedaAmerican Journal of Preventive Medicine|October 4, 2011
Public Health Area of Concentration: a model for integration into medical school curriculaSamuel Stebbins, Jason L Sanders, Charles J Vukotich, et al.Advances in Health Sciences Education : Theory and Practice|June 5, 2009
Defining the correctness of a diagnosis: differential judgments and expert knowledgeSteven L Kanter, Teresa A Brosenitsch, John F Mahoney, et al.Human Pathology|August 6, 2014
The Virtual Pathology Instructor: a medical student teaching tool developed using patient simulator softwareFiona E Craig, James B McGee, John F Mahoney, et al.Family Medicine|February 13, 2004
Evidence-based and population-based medicine: national implementation under the UME-21 projectJohn F Mahoney, Malcolm Cox, Robert E Gwyther, et al.Family Medicine|February 13, 2004
Collaborating to integrate curriculum in primary care medical education: successes and challenges from three US medical schoolsCatherine F Pipas, Deborah A Peltier, Leslie H Fall, et al.Evaluation and Program Planning|March 31, 2012
Developing a measure of local agency adaptation to emergencies: a metricRussell G Schuh, R Tony Eichelberger, Samuel Stebbins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401William Kevin Kelly, Susan Halabi, Michael Carducci, et al.Cancer|August 6, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)Rahul Aggarwal, Susan Halabi, William Kevin Kelly, et al.Pageof 2